Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XAEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.114EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.199EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.112EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.63EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GN.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.424EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.64EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.327EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.396EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.129EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.224EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.618EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.458EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
W.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.264.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.75.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CY.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBJ.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.1.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.56.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.13.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used